Viewing Study NCT04675827


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-02-08 @ 8:11 AM
Study NCT ID: NCT04675827
Status: TERMINATED
Last Update Posted: 2024-12-04
First Post: 2020-11-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade
Sponsor: Jules Bordet Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Breast Cancer View
None ER-Negative Breast Cancer View
None PR-Negative Breast Cancer View
None Node-negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View